此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Surgery for Thumb Base Osteoarthritis: Joint Replacement vs. Trapeziectomy (BASTION)

2026年6月22日 更新者:Uppsala University

BASTION - BASe of Thumb Osteoarthritis Management Non-inferiority Trial: Surgical Treatment of First Carpometacarpal Joint Osteoarthritis: A Comparison Between Joint Replacement and Trapeziectomy

The goal of this clinical trial is to learn if the surgical method with total joint arthroplasty, (TOUCH joint prosthesis), is as good as or better than the traditional surgical method, trapezectomy, to treat thumb base joint osteoarthritis.

The main questions it aims to answer are:

Does surgery with total joint arthroplasty provide better power grip and pinch grip strength compared to traditional surgery?

What is the long-term risk of complications for both methods?

Which method is more cost-effective for the healthcare system?

Researchers will compare total joint arthroplasty (TOUCH) to trapezectomy (a procedure where a bone in the thumb base is removed) to see which method provides the best results for the patient.

Participants will:

Be randomized to undergo either an operation with total joint arthroplasty or a trapezectomy.

Undergo an initial evaluation and a health economic cost analysis after one year.

Attend follow-up checkups at 2, 5, and 10 years post-surgery to evaluate long-term function and the durability of the prosthesis.

研究概览

详细说明

Background and Rationale:

Basal joint arthritis of the thumb (trapeziometacarpal osteoarthritis) is a common condition causing pain and reduced hand function. While trapeziectomy with ligament reconstruction/capsuloplasty has long been a gold standard, total joint arthroplasty, such as the TOUCH prosthesis, has gained popularity. However, there is a lack of high-quality prospective randomized controlled trials (RCTs) comparing these methods regarding long-term functional outcomes, complication rates, and cost-effectiveness. This study aims to compare the clinical and health-economic outcomes of total joint arthroplasty with TOUCH prosthesis versus trapeziectomy with capsuloplasty.

Study Design and Randomization:

This is a prospective, randomized controlled trial. Following informed consent obtained by the attending surgeon, participants are randomized to either:

  1. Total joint arthroplasty using the TOUCH prosthesis.
  2. Trapeziectomy with capsuloplasty. Randomization is performed in close proximity to the day of surgery. Due to the nature of the interventions, participants are informed of the surgical method postoperatively.

Procedures and Follow-up

  • Surgical Intervention: Both procedures are performed according to standardized institutional protocols.
  • Postoperative Care (Trapeziectomy): The thumb is immobilized in a cast for 3 weeks, followed by a standardized rehabilitation program led by occupational and physical therapists.
  • Postoperative Care (total joint arthroplasty): A stable soft dressing is applied for 3 weeks, followed by the same rehabilitation protocol.
  • Follow-up Schedule: Participants are evaluated at 3 weeks, 6 weeks, 12 weeks, 12 months, 24 months, 5 years, and 10 years postoperatively.
  • Imaging: Radiographic evaluations are performed for the prosthesis group at 6 weeks, 12 months, 24 months, 5 years, and 10 years to monitor for prosthesis loosening or "z-deformity" (MCP joint hyperextension) compared to the trapeziectomy group.

Data Management and Quality Assurance:

Data is collected and managed using REDCap (Research Electronic Data Capture) to ensure data integrity and validation. Physical informed consent forms are stored securely at the Department of Hand Surgery. Source data verification is performed by comparing registry data against electronic medical records and paper-based Case Report Forms (CRFs).

Sample Size and Power Calculation:

The primary outcome is Jamar grip strength at 12 months. Based on a Minimal Clinically Important Difference (MCID) of 6.5 kg and a standard deviation (SD) of 8.5 kg (derived from existing literature and pilot data), a power calculation (90% power, alpha 0.05, two-sided t-test) determined a requirement of 37 patients per group. To account for a 10% dropout rate, the total cohort size is set at 84 patients (42 per arm).

Health Economic Analysis:

A comprehensive health economic evaluation will be conducted to compare the total costs of both methods. This analysis includes:

  • Direct Costs: Implant costs, anesthesia, surgical time, and healthcare utilization (number of visits).
  • Indirect Costs: Duration of sick leave and time to return to work.
  • Secondary Metrics: Analgesic consumption (paracetamol and opioids), patient-reported quality of life (EQ-5D), and "pain-free days" based on NRS (Numerical Rating Scale) assessments.

The objective is to determine if the higher initial cost of the TOUCH prosthesis is offset by faster recovery, reduced sick leave, and improved long-term productivity.

研究类型

介入性

注册 (估计的)

84

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

  • 姓名:Elias Gardell, MD, attending hand surgeon
  • 电话号码:+46 (0) 186171544
  • 邮箱:elias.gardell@uu.se

学习地点

      • Uppsala、瑞典
        • 招聘中
        • Department of Handsurgery, Uppsala University Hospital
        • 接触:
          • Elias Gardell, MD, attending hand surgeon
          • 电话号码:+46(0) 186171544
          • 邮箱:elias.gardell@uu.se
        • 接触:
          • Sara Edsfeldt, MD, PhD, senior attending
          • 电话号码:+46 (0) 186119031
          • 邮箱:sara.edsfeldt@uu.se
        • 首席研究员:
          • Sara Edsfeldt, MD, PhD, senior attending
      • Örebro、瑞典
        • 尚未招聘
        • Örebro University Hospital
        • 接触:
        • 首席研究员:
          • Eva Lundqvist, MD, PhD, senior attending

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Age 40-80 years at inclusion
  • CMC-joint osteoarthritis grade 1-3 (Eaton-Littler classification)
  • Rest pain or pain reducing hand function with indication for surgery
  • Insufficient relief from non-operative treatment for ≥3 months (orthosis, OTC analgesics, cortisone injection)
  • Eligible for both prosthesis and trapezectomy per including surgeon
  • Non-smoker or complete smoking cessation ≥6 weeks prior to surgery

Exclusion Criteria:

  • Previous surgery to thumb base or STT-joint
  • Ongoing chronic pain condition
  • Dementia or cognitive impairment
  • Trapezium height <7 mm on plain radiograph
  • Active smoker
  • Osteoarthritis grade 4 (Eaton-Littler)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Arm 1 -Dual Mobility Prosthesis (TOUCH)
TOUCH Total Joint Arthroplasty (n=42). Implantation of TOUCH trapeziometacarpal prosthesis (Kerimedical). Soft bandage for 3 weeks postoperatively, followed by rehabilitation per national guidelines.
Surgical implantation of the TOUCH trapeziometacarpal total joint prosthesis (Kerimedical). The prosthesis consists of an uncemented stainless steel stem inserted into the first metacarpal and a dual cup mobility system with a polyethylene ball articulating against a metal cup fixed in the trapezium. The stem is available in straight or 15-degree angled neck configurations. Postoperative management consists of a stable soft dressing for 3 weeks to allow early controlled mobilization, followed by a standardized hand therapy rehabilitation protocol.
其他名称:
  • TOUCH Dual-Mobility Prosthesis
有源比较器:Arm 2 - Trapeziectomy and Capsular Reconstruction
Trapezectomy with capsuloplasty (n=42). Excision of trapezium with dorsal capsule flap capsuloplasty. Cast immobilization for 3 weeks postoperatively, followed by rehabilitation per national guidelines.
Surgical excision of the trapezium bone (trapeziectomy) followed by capsuloplasty using a distally based dorsal capsular flap, without tendon interposition. The capsular flap is sutured to stabilize the base of the first metacarpal. No implant or tendon graft is used. Postoperatively, a cast immobilizing the thumb in functional position is applied for 3 weeks, followed by a standardized hand therapy rehabilitation protocol.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Hand grip strength
大体时间:Measured at 12 months postoperatively
Hand grip strength (JAMAR dynamometer) at 12 months post operatively
Measured at 12 months postoperatively

次要结果测量

结果测量
措施说明
大体时间
Key-pinch grip strength
大体时间:Measured at 6 weeks, 12 weeks, and 12 months postoperatively
Key-pinch strength measured by pinch-gauge in kilograms
Measured at 6 weeks, 12 weeks, and 12 months postoperatively
Pinch grip strength
大体时间:Measured at 6 weeks, 12 weeks and 12 months postoperatively
3-finger pinch strength measured by pinch gauge in kilograms
Measured at 6 weeks, 12 weeks and 12 months postoperatively
Postoperative Pain Intensity on a Numeric Rating Scale (NRS)
大体时间:Measured at 6 weeks, 12 weeks and 12 months postoperatively
Pain measured with the Numerical Rating Scale (NRS) at rest and load, where 0 is "no pain" and 10 is "worst imaginable pain"
Measured at 6 weeks, 12 weeks and 12 months postoperatively
Range of movement
大体时间:Measured at 6 weeks, 12 weeks and 12 months postoperatively
Range of movement of thumb measured by physiotherapist. Extension, flexion, volar abduction, radial abduction. In degrees.
Measured at 6 weeks, 12 weeks and 12 months postoperatively
Metacarpophalangeal (MCP)-joint hyperextension
大体时间:Measured at 6 weeks, 12 weeks and 12 months postoperatively
Radiographic MCP-joint hyperextension (Z-deformity)
Measured at 6 weeks, 12 weeks and 12 months postoperatively
Complications
大体时间:Measured at 6 weeks, 12 weeks and 12 months postoperatively
Complications, such as trigger thumb, de Quervain's, reoperation, and infection, reported within 12 months of surgery.
Measured at 6 weeks, 12 weeks and 12 months postoperatively
Use of analgesics
大体时间:Measured at 12 months postoperatively
Total usage of analgesic during the post operative period.
Measured at 12 months postoperatively
Duration of sick leave
大体时间:Measured at 12 months postoperatively
Total duration of sick leave.
Measured at 12 months postoperatively
Patient-reported outcomes EQ-5D
大体时间:Measured at 6 weeks, 12 weeks and 12 months postoperatively
Patient-reported outcome of the hand surgery using validated questionnaire EQ-5D
Measured at 6 weeks, 12 weeks and 12 months postoperatively
Patient-reported outcomes PRWHE
大体时间:Measured at 6 weeks, 12 weeks and 12 months postoperatively
Patient-reported outcome of the hand surgery using validated questionnaire PRWHE
Measured at 6 weeks, 12 weeks and 12 months postoperatively

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 研究主任:Nils Hailer, MD, PhD. Professor、Department of orthopaedics and hand surgery, Akademiska hospital, Uppsala, Sweden
  • 首席研究员:Sara Edsfeldt, MD, PhD, senior attending、Department of orthopaedics and hand surgery, Akademiska hospital, Uppsala, Sweden
  • 学习椅:Sara Edsfeldt, MD, PhD, senior attending、Department of orthopaedics and hand surgery, Akademiska hospital, Uppsala, Sweden

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年7月1日

初级完成 (估计的)

2030年5月1日

研究完成 (估计的)

2038年3月1日

研究注册日期

首次提交

2026年4月27日

首先提交符合 QC 标准的

2026年5月4日

首次发布 (实际的)

2026年5月6日

研究记录更新

最后更新发布 (实际的)

2026年6月25日

上次提交的符合 QC 标准的更新

2026年6月22日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

De-identified individual participant data that underlie the results reported in this article (text, tables, figures, and appendices) will be made available to researchers who provide a methodologically sound proposal. Data will be available beginning 6 months and ending 5 years after publication. Requests should be directed to Central contact person. To gain access, data requestors will need to sign a data access agreement and provide proof of approval from the Swedish Ethical Review Authority.

IPD 共享时间框架

Beginning 6 months and ending 5 years after publication

IPD 共享访问标准

Access will be granted to qualified academic researchers who provide a methodologically sound scientific proposal. The request must be consistent with the informed consent provided by the participants. Access requires a formal Data Sharing Agreement (DSA) and a valid ethical approval from the Swedish Ethical Review Authority (Etikprövningsmyndigheten). The requesting party must also demonstrate that they have the necessary infrastructure to handle sensitive data according to GDPR

IPD 共享支持信息类型

  • 研究方案
  • 树液
  • 国际碳纤维联合会
  • 企业社会责任

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅